The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole Polinski

Affiliations

Nicole K Polinski. Dis Model Mech. 2023.

. 2023 Dec 1;16(12):dmm050605.

doi: 10.1242/dmm.050605. Epub 2023 Dec 20.

¹ The Michael J. Fox Foundation for Parkinson's Research, Grand Central Station PO Box 4777, New York, NY 10163USA.

No abstract available

Figures

1. Baptista, M. A. S., Merchant, K., Barrett, T., Bhargava, S., Bryce, D. K., Ellis, J. M., Estrada, A. A., Fell, M. J., Fiske, B. K., Fuji, R. N.et al. (2020). LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits. Sci. Transl. Med. 12, eaav0820. 10.1126/scitranslmed.aav0820 - DOI - PubMed
1. Gordon, R., Albornoz, E. A., Christie, D. C., Langley, M. R., Kumar, V., Mantovani, S., Robertson, A. A. B., Butler, M. S., Rowe, D. B., O'Neill, L. A.et al. (2018). Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med. 10, eaah4066. 10.1126/scitranslmed.aah4066 - DOI - PMC - PubMed
1. Kang, U. J., Boehme, A. K., Fairfoul, G., Shahnawaz, M., Ma, T. C., Hutten, S. J., Green, A. and Soto, C. (2019). Comparative study of cerebrospinal fluid α-synuclein seeding aggregation assays for diagnosis of Parkinson's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 34, 536-544. 10.1002/mds.27646 - DOI - PMC - PubMed